Fishwick Research
@FishwickGroup
The Offical Twitter feed of the Colin Fishwick Research Group. Specialists in Structure-Based Drug Design, Chemoinformatics & Bioinformatics
123 Following 178 Followers 94 Posts
Latest posts 5
New paper from the group: Exploitation of a novel allosteric binding region in DNA gyrase and its implications for antibacterial drug discove… pubmed.ncbi.nlm.nih.gov/34605249/
Our latest manuscript is available on ChemRxiv: De Novo Design of Type II Topoisomerase Inhibitors as Potential Antimicrobial Agents Targeting a Novel Binding Region | ChemRxiv doi.org/10.33774/chemr…
chemrxiv.org De Novo Design of Type II Topoisomerase Inhibitors as Potential Antimicrobial Agents Targeting a... By 2050 it is predicted that antimicrobial resistance will be responsible for 10 million global deaths annually, costing the world economy $100 trillion. Clearly, strategies to address this problem... Come and join us at Leeds! 😊
Job Opportunity at University of Leeds: Research Fellow in Medicinal Chemistry jobs.leeds.ac.uk/EPSCH1037
Job Opportunity at University of Leeds: Research Fellow in Medicinal Chemistry jobs.leeds.ac.uk/EPSCH1037
Our latest work from former PhD student @LewisTu52514415 looking at selective FGFR2 kinase inhibitors is now available as a pre-print on ChemRxiv doi.org/10.33774/chemr… Congrats to Lewis, Ryan & Kyle.
chemrxiv.org From Fragment to Lead: A Structure-Guided Approach Towards a Selective FGFR2 Inhibitor | ChemRxiv Fibroblast growth factor receptors (FGFRs) are implicated in a range of cancers with several pan-kinase and selective-FGFR inhibitors currently being evaluated in clinical trials for FGFR-implicated...